Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Blum

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Hematology. American Society of Hematology. Education Program|January 18, 2011
How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromesWilliam Blum
Best Practice & Research. Clinical Haematology|November 29, 2016
Why the stagnation in effective therapy for MDS?William Blum
Current Opinion in Hematology|January 22, 2013
Emerging immunotherapies in older adults with acute myeloid leukemiaSumithira Vasu, William Blum
Best Practice & Research. Clinical Haematology|March 18, 2008
New approaches in acute myeloid leukemiaWilliam Blum, Guido Marcucci
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel therapies in AML: reason for hope or just hype?Karilyn Larkin, William Blum
Clinical Advances in Hematology & Oncology : H&O|February 24, 2006
Targeting epigenetic changes in acute myeloid leukemiaWilliam Blum, Guido Marcucci
Seminars in Thrombosis and Hemostasis|May 26, 2007
Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndromeWilliam Blum, Pierluigi Porcu
Current Opinion in Hematology|January 19, 2017
Making the most of hypomethylating agents in myelodysplastic syndromeGeetika Bhatt, William Blum
Current Opinion in Hematology|January 15, 2019
Progress in the problem of relapsed or refractory acute myeloid leukemiaAlice S Mims, William Blum
International Journal of Occupational and Environmental Health|May 15, 2010
The unique developmental considerations of youth-related work injuriesMay Sudhinaraset, Robert William Blum
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Hematology. American Society of Hematology. Education Program|January 18, 2011
How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromesWilliam Blum
Best Practice & Research. Clinical Haematology|November 29, 2016
Why the stagnation in effective therapy for MDS?William Blum
Current Opinion in Hematology|January 22, 2013
Emerging immunotherapies in older adults with acute myeloid leukemiaSumithira Vasu, William Blum
Best Practice & Research. Clinical Haematology|March 18, 2008
New approaches in acute myeloid leukemiaWilliam Blum, Guido Marcucci
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel therapies in AML: reason for hope or just hype?Karilyn Larkin, William Blum
Clinical Advances in Hematology & Oncology : H&O|February 24, 2006
Targeting epigenetic changes in acute myeloid leukemiaWilliam Blum, Guido Marcucci
Seminars in Thrombosis and Hemostasis|May 26, 2007
Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndromeWilliam Blum, Pierluigi Porcu
Current Opinion in Hematology|January 19, 2017
Making the most of hypomethylating agents in myelodysplastic syndromeGeetika Bhatt, William Blum
Current Opinion in Hematology|January 15, 2019
Progress in the problem of relapsed or refractory acute myeloid leukemiaAlice S Mims, William Blum
International Journal of Occupational and Environmental Health|May 15, 2010
The unique developmental considerations of youth-related work injuriesMay Sudhinaraset, Robert William Blum
Pageof 12